Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

Withdrawn before enrolling · Phase 4

Conditions studied: Atrial Fibrillation

In brief

The objective is to compare the progression of Atrial Fib (AF) burden by continuous monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation (PVI) versus anti-arrhythmic drug (AAD) therapy.

Key facts

Study ID

NCT01505296

Run by

Valley Health System

People needed

0

Starts

2011-12-01

Expected to finish

2014-01-01

Last updated by the study team

2014-12-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with recently diagnosed paroxysmal AF who are eligible to receive specific rhythm control therapy

You may not qualify if…

• Previous treatment with Class IC or class III AAD
• Previous AF ablation procedure
• Congestive heart failure (NYHA III-IV functional class)
• Left Ventricle ejection fraction less than 35%
• Left atrial diameter > 55mm
• Unwillingness to participate

Where it is running

• Valley Health System — Ridgewood, New Jersey, United States
• State Research Institute of Circulation Pathology — Novosibirsk, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.